Management of patients with implantable cardioverter defibrillators at emergency departments

被引:6
|
作者
Liu, Chung-Pin
Ho, Yi-Lwun
Lin, Yen-Hung
Liu, Yen-Bin
Chang, Wei-Tien
Huang, Chien-Hua
Chen, Wen-Jone
机构
[1] Yauns Gen Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei 100, Taiwan
关键词
D O I
10.1136/emj.2006.037788
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: With rapid improvements in technology and accumulation of clinical evidence, the implantable cardioverter defibrillator (ICD) has become a standard treatment for either primary or secondary prevention of sudden cardiac death. However, no analysis based on the perspective of emergency department has been reported, and managing patients with ICD remains a challenge to the emergency department doctors. Methods: This study reviewed the emergency department visits of patients who received ICD implantation in a single university hospital from 1995 to 2004. The baseline demographic and laboratory data were compared between groups with the non-parametric method of the Mann-Whitney U test for continuous data and the x 2 test for categorical data; p < 0.05 was considered significant. Results: 81 patients (56 men and 25 women) were included in this study. 43% of patients had at least one emergency department visit during the follow-up period, and a total of 86 emergency department visits were recorded. The most frequent aetiology of emergency department visits was ICD discharge (37 episodes; 43.1%) and the most frequent presenting symptom was electric shock sensation (25 episodes; 29.1%). Only 11 (12.8%) emergency department visits were because of non-cardiac aetiologies. Patients with emergency department visits had significant lower left ventricular ejection fraction (mean (SD) 41.5 (19.8) v 55.2 (18.4) ejection fraction units; p = 0.005) and more use of warfarin (8.6% v 0%; p, 0.05). Although most emergency department visits were device or arrhythmia related, the acute coronary syndrome and congestive heart failure still accounted for 27.9% of hospital returns in combination. Conclusions: Defibrillator discharge, acute coronary syndrome and heart failure constitute most aetiologies of emergency department visits of patients with ICD. The risk factors include lower left ventricular ejection fraction and use of warfarin.
引用
收藏
页码:106 / 109
页数:4
相关论文
共 50 条
  • [21] Implantable cardioverter-defibrillators in dialysis patients
    Mills, Mark T.
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 187 - 188
  • [22] The use of implantable cardioverter defibrillators in pediatric patients
    V Campagnucci
    A Silva
    W Pereira
    A Peroni
    E Chamlian
    S Gandra
    A Scatolini
    U Lourenço
    F Silva
    L Rivetti
    Journal of Cardiothoracic Surgery, 8 (Suppl 1)
  • [23] Avoidance behaviors in patients with implantable cardioverter defibrillators
    Lemon, J
    Edelman, S
    Kirkness, A
    HEART & LUNG, 2004, 33 (03): : 176 - 182
  • [24] MORE ON PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    EMBIL, JM
    GEDDES, JS
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) : 892 - 893
  • [25] Predictors of outcome in patients with implantable cardioverter defibrillators
    Anvari, A
    Gotsauner-Wolf, M
    Türel, Z
    Stix, G
    Podesser, B
    Mayer, C
    Schuster, E
    Schmidinger, H
    CARDIOLOGY, 1998, 90 (03) : 180 - 186
  • [26] Recommendations for driving of patients with implantable cardioverter defibrillators
    Jung, W
    Anderson, M
    Camm, AJ
    Jordaens, L
    Petch, MC
    Rosenqvist, M
    Santini, M
    Luderitz, B
    EUROPEAN HEART JOURNAL, 1997, 18 (08) : 1210 - 1219
  • [27] Guidelines on the management of implantable cardioverter defibrillators at the end of life
    Datino, T.
    Rexach, L.
    Vidan, M. T.
    Alonso, A.
    Gandara, A.
    Ruiz-Garcia, J.
    Fontecha, B.
    Martinez-Selles, M.
    REVISTA CLINICA ESPANOLA, 2014, 214 (01): : 31 - 37
  • [28] Management of infected pacemakers and implantable cardioverter-defibrillators
    Sohail, M. R.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (07)
  • [29] Management of diaphragmatic myopotential oversensing in implantable cardioverter defibrillators
    Day, J
    Lauer, M
    Young, C
    Han, J
    Goold, P
    Chun, S
    Liem, LB
    EUROPACE 2001, 2001, : 583 - 588
  • [30] INFECTIONS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - APPROACH TO MANAGEMENT
    SPRATT, KA
    BLUMBERG, EA
    WOOD, CA
    KUTALEK, SP
    REBOLI, AC
    CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) : 679 - 685